Generic spec for dry-powder inhalers provides regulatory and quality updates
Cambridge Consultants expects DPI use to expand into new treatment areas
Out With Pedigree; In With Patient Safety
New group of injectables manufacturers tussles with USP over use of labeling ‘real estate’ on vial caps
3PLs Rise in Forward-Thinking Supply Chain Models
Moving boxes is becoming just one of a growing slate of services from third-party logistics (3PL) providers
A Pitched Battle in Cardiovascular Drug Marketing
Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment
Merck Is the Best-Regarded Manufacturer Among Managed-Care Execs; Genentech Among Oncology KOLs
Surveys from SDI and Market Strategies International score companies on their promotional practices and business relationships
Wyeth Loses Supreme Court Case Over 'Implied' Pre-Emption
Expect a flood of product-liability suits in the aftermath of Wyeth vs. Levine
Syringe Design Gets a Makeover
Two prefilled-syringe projects emphasize user friendliness
Refinements in Cold Chain Secondary Packaging
Optimized dimensionality is the goal of new products from MTS and Cold Chain Technologies
Inmar Rebrands Reverse-Logistics and Related Business Units
Unified corporate image emphasizes supply chain services
Healthcare Information Technology Gets A Boost From Obama Reinvestment Law
American Recovery and Reinvestment Act allocates $18 billion for HIT
The Packaging Contribution to Patient Adherence
Contract packagers are multiplying their product offerings to meet marketing and patient-safety concerns
Moving the Dial on Patient Adherence
FDA to Require REMS of Opioid-Based Drugs
People on the Move-March
BIOPHARMA INDUSTRY
Oracle to buy Relsys, adding to adverse-event management capabilities
Relsys’ ‘structured signal management’ analyzes patient data for trends
Pharma service providers continue to invest in supply-chain optimization solutions
DDN goes with Axway’s Trade Activity Manager; repackager Apace Packaging chooses Supplyscape’s Nexus platform
Pharma reevaluates CME sponsorship
Drugmakers face difficulty justifying expenses amid restrictions
Here We Go Again on 'Re-Importation'
Bipartisan group of senators sponsor a revived drug-importation bill
Stem Cell Therapy: Business Models Begin to Take Shape
Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy
Organizing Your Commercial Compliance Programs
Regulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels
Pharma 2020: Marketing the Future
A New Business Model for Pharma Innovation
The studio model: how film industry practices can boost pharmaceutical creativity
More authentication vendors offer up anti-counterfeiting technologies
While track-and-trace initiatives stumble along, more technology firms provide authentication solutions
New industry initiative to enhance supply-chain integrity is launched by Amgen
Rx-360 seeks to bring manufacturers and suppliers together to advance operating standards; meanwhile, Congress gets busy writing bills
Off-label prescribing enjoys health plan support
Referencing in pharmaceutical compendia and peer-reviewed literature are a guide
U.S. biopharma sales grew 1.3% in 2008, says IMS Health
Dispensed prescription volume grew 0.9%
Medication therapy management program attracts Medicare patients
Program appears to improve medication adherence and decrease therapeutic duplications
Wyeth loses Supreme Court case over 'implied' pre-emption
Industry, regulators hit reset button on product serialization
While California’s e-pedigree initiative sits on a shelf, actions in Washington and Brussels point to renewed efforts for track-and-trace of pharmaceuticals
